Genomic drivers leading to glioblastoma metastasis are not fully understood, but mutations in TP53, IGFBP2, BRACA1, ARID1A, SMARCB1 and matrix metalloproteinase have been associated with tumor progression and dissemination. The gene discussed is TP53; the disease is neoplasm.